Table: Jcr Pharmaceuticals -Q1 group results

JCR Pharmaceuticals

30/07/2025 08:00

Jul 30 (Reuters)- 
             Jcr Pharmaceuticals Co., Ltd. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   3 months ended      3 months ended       Year to 
                  Jun 30, 2025        Jun 30, 2024     Mar 31, 2026 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               8.57                8.15             37.80    
                   (+5.2 pct)          (-24.6 pct)      (+14.3 pct) 
  Operating       loss 606 mln        loss 296 mln          2.60    
  Recurring       loss 749 mln        loss 257 mln          2.40    
  Net             loss 546 mln           201 mln            3.00    
                                       (-87.5 pct)                  
  EPS             loss 4.48 yen         1.61 yen         24.22 yen  
  EPS Diluted                           1.61 yen                    
  Ann Div                               20.00 yen        20.00 yen  
  -Q2 div                               10.00 yen        10.00 yen  
  -Q4 div                               10.00 yen        10.00 yen  
  
  NOTE - Jcr Pharmaceuticals Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4552.T